Matthew T. Wiley - 30 Jun 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Commercial Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Matthew Wiley
Issuer symbol
VYNE
Transactions as of
30 Jun 2021
Transactions value $
-$18,080
Form type
4
Filing time
02 Jul 2021, 16:36:53 UTC
Next filing
19 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$18.1K -5.15K -4.5% $3.51 109K 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.